{"count": 38, "results": [{"_id": "37753037", "pmid": 37753037, "pmcid": "PMC10519644", "title": "Effect of Metformin (MTF) Intervention During Pregnancy in Women With Polycystic Ovarian Syndrome (PCOS): A Systematic Review", "journal": "Cureus", "authors": ["Kanda S", "Chatha U", "Odoma VA", "Pitliya A", "AlEdani EM", "Bhangu JK", "Javed K", "Manshahia PK", "Nahar S", "Hamid P"], "date": "2023-08-26T00:00:00Z", "doi": "10.7759/cureus.44166", "meta_date_publication": "2023 Aug", "meta_volume": "15", "meta_issue": "8", "meta_pages": "e44166", "score": 50264.074, "text_hl": "...It was found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MTF@@@ treatment during pregnancy reduced the risk of @DISEASE_Hypertension_Pregnancy_Induced @DISEASE_MESH:D046110 @@@PIH@@@, @DISEASE_Pre_Eclampsia @DISEASE_MESH:D011225 @@@preeclampsia@@@, @DISEASE_Fetal_Macrosomia @DISEASE_MESH:D005320 @@@macrosomia@@@ (abnormally large birth weight), and @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@preterm delivery@@@ compared to placebo. ", "citations": {"NLM": "Kanda S, Chatha U, Odoma VA, Pitliya A, AlEdani EM, Bhangu JK, Javed K, Manshahia PK, Nahar S, Hamid P. Effect of Metformin (MTF) Intervention During Pregnancy in Women With Polycystic Ovarian Syndrome (PCOS): A Systematic Review Cureus. 2023 Aug;15(8):e44166. PMID: 37753037", "BibTeX": "@article{37753037, title={Effect of Metformin (MTF) Intervention During Pregnancy in Women With Polycystic Ovarian Syndrome (PCOS): A Systematic Review}, author={Kanda S and Chatha U and Odoma VA and Pitliya A and AlEdani EM and Bhangu JK and Javed K and Manshahia PK and Nahar S and Hamid P}, journal={Cureus}, volume={15}, number={8}, pages={e44166}}"}}, {"_id": "37401946", "pmid": 37401946, "pmcid": "PMC10442287", "title": "Position paper of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), and the Italian Study Group of Diabetes in pregnancy: Metformin use in pregnancy", "journal": "Acta Diabetol", "authors": ["Sciacca L", "Bianchi C", "Burlina S", "Formoso G", "Manicardi E", "Sculli MA", "Resi V"], "date": "2023-07-04T00:00:00Z", "doi": "10.1007/s00592-023-02137-5", "meta_date_publication": "2023 Jul 4", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50263.25, "text_hl": "Moreover, a per-protocol analysis revealed a reduction in @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@preterm delivery@@@ in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treated @SPECIES_9606 @@@women@@@ (from 10 to 2.8%; 95% CI, 0.9-13.9; p < 0.05). ", "citations": {"NLM": "Sciacca L, Bianchi C, Burlina S, Formoso G, Manicardi E, Sculli MA, Resi V. Position paper of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), and the Italian Study Group of Diabetes in pregnancy: Metformin use in pregnancy Acta Diabetol. 2023 Jul 4;():. PMID: 37401946", "BibTeX": "@article{37401946, title={Position paper of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), and the Italian Study Group of Diabetes in pregnancy: Metformin use in pregnancy}, author={Sciacca L and Bianchi C and Burlina S and Formoso G and Manicardi E and Sculli MA and Resi V}, journal={Acta Diabetol}}"}}, {"_id": "34957166", "pmid": 34957166, "pmcid": "PMC8696129", "title": "Physical Exercise vs. Metformin to Improve Delivery- and Newborn-Related Outcomes Among Pregnant Women With Overweight: A Network Meta-Analysis", "journal": "Front Med (Lausanne)", "authors": ["Pascual-Morena C", "Cavero-Redondo I", "Álvarez-Bueno C", "Martínez-Hortelano JA", "Reina-Gutiérrez S", "Saz-Lara A", "Núñez de Arenas-Arroyo S", "Martínez-Vizcaíno V"], "date": "2021-12-09T00:00:00Z", "doi": "10.3389/fmed.2021.796009", "meta_date_publication": "2021", "meta_volume": "8", "meta_issue": "", "meta_pages": "796009", "score": 50263.03, "text_hl": "There were statistically significant differences between the baseline body mass index of the intervention groups for @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@preterm birth@@@, with the baseline body mass index of the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ intervention being higher than the exercise interventions. ", "citations": {"NLM": "Pascual-Morena C, Cavero-Redondo I, Álvarez-Bueno C, Martínez-Hortelano JA, Reina-Gutiérrez S, Saz-Lara A, Núñez de Arenas-Arroyo S, Martínez-Vizcaíno V. Physical Exercise vs. Metformin to Improve Delivery- and Newborn-Related Outcomes Among Pregnant Women With Overweight: A Network Meta-Analysis Front Med (Lausanne). 2021;8():796009. PMID: 34957166", "BibTeX": "@article{34957166, title={Physical Exercise vs. Metformin to Improve Delivery- and Newborn-Related Outcomes Among Pregnant Women With Overweight: A Network Meta-Analysis}, author={Pascual-Morena C and Cavero-Redondo I and Álvarez-Bueno C and Martínez-Hortelano JA and Reina-Gutiérrez S and Saz-Lara A and Núñez de Arenas-Arroyo S and Martínez-Vizcaíno V}, journal={Front Med (Lausanne)}, volume={8}, pages={796009}}"}}, {"_id": "39236318", "pmid": 39236318, "title": "Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia.", "journal": "Obstet Gynecol", "authors": ["Patel M", "Battarbee AN", "Refuerzo JS", "Zork N", "Eichelberger K", "Ramos GA", "Olson G", "Durnwald C", "Landon MB", "Aagaard KM", "Wallace K", "Scifres C", "Rosen T", "Mulla W", "Valent A", "Longo S", "Boggess KA"], "date": "2024-09-05T00:00:00Z", "doi": "10.1097/AOG.0000000000005720", "meta_date_publication": "2024 Sep 5", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50262.105, "text_hl": "Association Between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use in Early Gestational @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@or Type 2 Diabetes@@@ in Pregnancy and @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@Preterm Preeclampsia@@@.", "citations": {"NLM": "Patel M, Battarbee AN, Refuerzo JS, Zork N, Eichelberger K, Ramos GA, Olson G, Durnwald C, Landon MB, Aagaard KM, Wallace K, Scifres C, Rosen T, Mulla W, Valent A, Longo S, Boggess KA. Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia. Obstet Gynecol. 2024 Sep 5;():. PMID: 39236318", "BibTeX": "@article{39236318, title={Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia.}, author={Patel M and Battarbee AN and Refuerzo JS and Zork N and Eichelberger K and Ramos GA and Olson G and Durnwald C and Landon MB and Aagaard KM and Wallace K and Scifres C and Rosen T and Mulla W and Valent A and Longo S and Boggess KA}, journal={Obstet Gynecol}}"}}, {"_id": "37409227", "pmid": 37409227, "pmcid": "PMC10319127", "title": "Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond", "journal": "Front Endocrinol (Lausanne)", "authors": ["Tosti G", "Barberio A", "Tartaglione L", "Rizzi A", "Di Leo M", "Viti L", "Sirico A", "De Carolis S", "Pontecorvi A", "Lanzone A", "Pitocco D"], "date": "2023-06-20T00:00:00Z", "doi": "10.3389/fendo.2023.1176623", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1176623", "score": 50261.23, "text_hl": "The @SPECIES_9606 @@@women@@@ clearly preferred @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to @GENE_INS @GENE_3630 @@@insulin@@@ treatment and there was no difference in the composite primary outcomes (p = 0.95), and even in the single outcomes included in the composite, severe @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@hypoglycemia@@@ was less common in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group (p = 0.008), but @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@preterm birth@@@ was more common in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group (p = 0.04). ", "citations": {"NLM": "Tosti G, Barberio A, Tartaglione L, Rizzi A, Di Leo M, Viti L, Sirico A, De Carolis S, Pontecorvi A, Lanzone A, Pitocco D. Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond Front Endocrinol (Lausanne). 2023;14():1176623. PMID: 37409227", "BibTeX": "@article{37409227, title={Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond}, author={Tosti G and Barberio A and Tartaglione L and Rizzi A and Di Leo M and Viti L and Sirico A and De Carolis S and Pontecorvi A and Lanzone A and Pitocco D}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1176623}}"}}, {"_id": "36916886", "pmid": 36916886, "pmcid": "PMC10438881", "title": "Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS", "journal": "J Clin Endocrinol Metab", "authors": ["Ryssdal M", "Vanky E", "Stokkeland LMT", "Jarmund AH", "Steinkjer B", "Løvvik TS", "Madssen TS", "Iversen AC", "Giskeødegård GF"], "date": "2023-03-14T00:00:00Z", "doi": "10.1210/clinem/dgad145", "meta_date_publication": "2023 Mar 14", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50259.164, "text_hl": "Maternal @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ and the prevalence of @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@preterm birth@@@ were significantly lower in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group (P < .05), as previously reported. ", "citations": {"NLM": "Ryssdal M, Vanky E, Stokkeland LMT, Jarmund AH, Steinkjer B, Løvvik TS, Madssen TS, Iversen AC, Giskeødegård GF. Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS J Clin Endocrinol Metab. 2023 Mar 14;():. PMID: 36916886", "BibTeX": "@article{36916886, title={Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS}, author={Ryssdal M and Vanky E and Stokkeland LMT and Jarmund AH and Steinkjer B and Løvvik TS and Madssen TS and Iversen AC and Giskeødegård GF}, journal={J Clin Endocrinol Metab}}"}}, {"_id": "32396212", "pmid": 32396212, "title": "Metformin therapy in pregnancy [Zastosowanie metforminy w ciazy].", "journal": "Endokrynol Pol", "authors": ["Krupej-Kędzierska J", "Cichocka E", "Kędzierski L", "Okopień B", "Gumprecht J"], "date": "2020-01-01T00:00:00Z", "doi": "10.5603/EP.a2020.0016", "meta_date_publication": "2020", "meta_volume": "71", "meta_issue": "2", "meta_pages": "184-195", "score": 50253.957, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ therapy in pregnancy [Zastosowanie metforminy w ciazy].", "citations": {"NLM": "Krupej-Kędzierska J, Cichocka E, Kędzierski L, Okopień B, Gumprecht J. Metformin therapy in pregnancy [Zastosowanie metforminy w ciazy]. Endokrynol Pol. 2020;71(2):184-195. PMID: 32396212", "BibTeX": "@article{32396212, title={Metformin therapy in pregnancy [Zastosowanie metforminy w ciazy].}, author={Krupej-Kędzierska J and Cichocka E and Kędzierski L and Okopień B and Gumprecht J}, journal={Endokrynol Pol}, volume={71}, number={2}, pages={184-195}}"}}, {"_id": "34571574", "pmid": 34571574, "title": "Gestational metformin administration in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized control studies.", "journal": "J Obstet Gynaecol Res", "authors": ["Cao Q", "Hu Y", "Fu J", "Huang X", "Wu L", "Zhang J", "Huang W"], "date": "2021-12-01T00:00:00Z", "doi": "10.1111/jog.15044", "meta_date_publication": "2021 Dec", "meta_volume": "47", "meta_issue": "12", "meta_pages": "4148-4157", "score": 50251.594, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ administration in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ pregnancies was associated with reduced @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@preterm delivery@@@ risk and larger neonatal head circumference.", "citations": {"NLM": "Cao Q, Hu Y, Fu J, Huang X, Wu L, Zhang J, Huang W. Gestational metformin administration in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized control studies. J Obstet Gynaecol Res. 2021 Dec;47(12):4148-4157. PMID: 34571574", "BibTeX": "@article{34571574, title={Gestational metformin administration in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized control studies.}, author={Cao Q and Hu Y and Fu J and Huang X and Wu L and Zhang J and Huang W}, journal={J Obstet Gynaecol Res}, volume={47}, number={12}, pages={4148-4157}}"}}, {"_id": "35834091", "pmid": 35834091, "title": "Efficacy and safety of metformin compared to insulin in gestational diabetes: a systemic review and meta-analysis of Chinese randomized controlled trials.", "journal": "Int J Clin Pharm", "authors": ["Li F", "Liu L", "Hu Y", "Marx CM", "Liu W"], "date": "2022-10-01T00:00:00Z", "doi": "10.1007/s11096-022-01438-z", "meta_date_publication": "2022 Oct", "meta_volume": "44", "meta_issue": "5", "meta_pages": "1102-1113", "score": 50249.344, "text_hl": "Subgroup analysis confirmed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has better outcomes than all types of @GENE_INS @GENE_3630 @@@insulin@@@ except for @DISEASE_Respiratory_Distress_Syndrome @DISEASE_MESH:D012128 @@@RDS@@@, @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@premature birth@@@, 2 h postprandial blood @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@, and glycated hemoglobin. ", "citations": {"NLM": "Li F, Liu L, Hu Y, Marx CM, Liu W. Efficacy and safety of metformin compared to insulin in gestational diabetes: a systemic review and meta-analysis of Chinese randomized controlled trials. Int J Clin Pharm. 2022 Oct;44(5):1102-1113. PMID: 35834091", "BibTeX": "@article{35834091, title={Efficacy and safety of metformin compared to insulin in gestational diabetes: a systemic review and meta-analysis of Chinese randomized controlled trials.}, author={Li F and Liu L and Hu Y and Marx CM and Liu W}, journal={Int J Clin Pharm}, volume={44}, number={5}, pages={1102-1113}}"}}, {"_id": "34987051", "pmid": 34987051, "pmcid": "PMC8734020", "title": "Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study", "journal": "BMJ Open Diabetes Res Care", "authors": ["Brand KMG", "Saarelainen L", "Sonajalg J", "Boutmy E", "Foch C", "Vääräsmäki M", "Morin-Papunen L", "Schlachter J", "CLUE Study Group", "Hakkarainen KM", "Korhonen P"], "date": "2022-01-01T00:00:00Z", "doi": "10.1136/bmjdrc-2021-002363", "meta_date_publication": "2022 Jan", "meta_volume": "10", "meta_issue": "1", "meta_pages": "", "score": 50247.82, "text_hl": "Among the secondary outcomes, increased risk of small for gestational age (SGA) was observed for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (IPTW-weighted OR 1.65, 95% CI 1.16 to 2.34); increased risk of large for gestational age, @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@preterm birth@@@ and @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@hypoglycemia@@@ was observed for combination treatment. ", "citations": {"NLM": "Brand KMG, Saarelainen L, Sonajalg J, Boutmy E, Foch C, Vääräsmäki M, Morin-Papunen L, Schlachter J, CLUE Study Group, Hakkarainen KM, Korhonen P. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study BMJ Open Diabetes Res Care. 2022 Jan;10(1):. PMID: 34987051", "BibTeX": "@article{34987051, title={Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study}, author={Brand KMG and Saarelainen L and Sonajalg J and Boutmy E and Foch C and Vääräsmäki M and Morin-Papunen L and Schlachter J and CLUE Study Group and Hakkarainen KM and Korhonen P}, journal={BMJ Open Diabetes Res Care}, volume={10}, number={1}}"}}]}